In a phase 2 clinical trial, researchers examined baricitinib and NB-UVB in adults with severe vitiligo in the dermatology ...

Leaders from the WHO responded with a statement saying that the organization hopes the United States will reconsider. “WHO ...

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines, including vaccines for avian flu ...

A panelist discusses how she carefully transitions patients to neurokinin-targeted therapies by establishing realistic timelines for symptom improvement and actively monitoring patient response while ...

Appearing to stick closely to what was shown on teleprompters to the left and right of the podium with the familiar ...

The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...

CEO Andrew Witty promised that UnitedHealthcare would work to speed up turnaround times for approval of some procedures and ...

In 2024, UnitedHealth Group saw full year revenue grow 8% over 2023 to reach $400.3 billion. Adjusted earnings from ...

A South Korean study explored the link between lifestyle decisions beginning in infancy and persistent atopic dermatitis, ...

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...

But many existing models fall short of adhering to established best practices for economic evaluation, the review authors ...

Berge will serve in this role through the end of 2026, marking another milestone in her successful career in healthcare.